The mitigation effect of the Fuziline and GA compatibility groups on mice with HF was evaluated based on changes in the serum levels of the biomarkers, CAN, LDH, CK, and CTnT (Figure 2D). The gene discussed is TNNT2; the disease is hydrops fetalis.